| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.42 | 4e-06 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.37 | 4e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.24 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |